Annual Working Capital
$345.25 M
-$82.61 M-19.31%
31 December 2023
Summary:
Vanda Pharmaceuticals annual working capital is currently $345.25 million, with the most recent change of -$82.61 million (-19.31%) on 31 December 2023. During the last 3 years, it has risen by +$2.04 million (+0.59%). VNDA annual working capital is now -61.22% below its all-time high of $890.28 million, reached on 01 December 2003.VNDA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$343.30 M
-$2.09 M-0.61%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly working capital is currently $343.30 million, with the most recent change of -$2.09 million (-0.61%) on 30 September 2024. Over the past year, it has dropped by -$108.44 million (-24.00%). VNDA quarterly working capital is now -24.00% below its all-time high of $451.74 million, reached on 30 September 2023.VNDA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | -24.0% |
| 3 y3 years | +0.6% | -11.9% |
| 5 y5 years | +40.3% | +56.0% |
VNDA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.3% | +0.6% | -24.0% | at low |
| 5 y | 5 years | -19.3% | +40.3% | -24.0% | +56.0% |
| alltime | all time | -61.2% | +2228.4% | -24.0% | +2860.8% |
Vanda Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $343.30 M(-0.6%) |
| June 2024 | - | $345.39 M(-0.2%) |
| Mar 2024 | - | $346.08 M(+0.2%) |
| Dec 2023 | $345.25 M(-19.3%) | $345.25 M(-23.6%) |
| Sept 2023 | - | $451.74 M(+1.3%) |
| June 2023 | - | $446.11 M(+1.4%) |
| Mar 2023 | - | $439.91 M(+2.8%) |
| Dec 2022 | $427.86 M(+5.9%) | $427.86 M(+3.2%) |
| Sept 2022 | - | $414.48 M(+1.5%) |
| June 2022 | - | $408.50 M(+1.7%) |
| Mar 2022 | - | $401.53 M(-0.6%) |
| Dec 2021 | $403.88 M(+17.7%) | $403.88 M(+3.6%) |
| Sept 2021 | - | $389.81 M(+4.0%) |
| June 2021 | - | $374.66 M(+4.2%) |
| Mar 2021 | - | $359.44 M(+4.7%) |
| Dec 2020 | $343.21 M(+16.5%) | $343.21 M(+4.6%) |
| Sept 2020 | - | $328.18 M(+2.8%) |
| June 2020 | - | $319.27 M(+5.9%) |
| Mar 2020 | - | $301.52 M(+2.3%) |
| Dec 2019 | $294.63 M(+19.7%) | $294.63 M(+33.9%) |
| Sept 2019 | - | $220.01 M(-13.1%) |
| June 2019 | - | $253.23 M(+2.4%) |
| Mar 2019 | - | $247.22 M(+0.4%) |
| Dec 2018 | $246.12 M(+147.4%) | $246.12 M(+5.8%) |
| Sept 2018 | - | $232.56 M(+4.7%) |
| June 2018 | - | $222.22 M(+5.6%) |
| Mar 2018 | - | $210.48 M(+111.6%) |
| Dec 2017 | $99.49 M(-19.7%) | $99.49 M(+1.3%) |
| Sept 2017 | - | $98.18 M(-1.0%) |
| June 2017 | - | $99.17 M(+3.7%) |
| Mar 2017 | - | $95.59 M(-22.8%) |
| Dec 2016 | $123.86 M(+7.5%) | $123.86 M(+3.4%) |
| Sept 2016 | - | $119.73 M(+10.2%) |
| June 2016 | - | $108.61 M(+1.1%) |
| Mar 2016 | - | $107.41 M(-6.8%) |
| Dec 2015 | $115.23 M(-14.0%) | $115.23 M(-10.0%) |
| Sept 2015 | - | $127.99 M(-0.9%) |
| June 2015 | - | $129.18 M(-0.9%) |
| Mar 2015 | - | $130.38 M(-2.7%) |
| Dec 2014 | $133.94 M(+30.3%) | $133.94 M(+415.3%) |
| Sept 2014 | - | $25.99 M(-21.1%) |
| June 2014 | - | $32.93 M(-45.2%) |
| Mar 2014 | - | $60.11 M(-41.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $102.76 M(+9.7%) | $102.76 M(-10.8%) |
| Sept 2013 | - | $115.17 M(+50.7%) |
| June 2013 | - | $76.42 M(-9.2%) |
| Mar 2013 | - | $84.14 M(-10.2%) |
| Dec 2012 | $93.70 M(-23.1%) | $93.70 M(-10.9%) |
| Sept 2012 | - | $105.22 M(-9.0%) |
| June 2012 | - | $115.60 M(-10.2%) |
| Mar 2012 | - | $128.69 M(+5.6%) |
| Dec 2011 | $121.88 M(-28.1%) | $121.88 M(-7.0%) |
| Sept 2011 | - | $131.08 M(-17.4%) |
| June 2011 | - | $158.66 M(-4.0%) |
| Mar 2011 | - | $165.22 M(-2.6%) |
| Dec 2010 | $169.55 M(-6.5%) | $169.55 M(-2.5%) |
| Sept 2010 | - | $173.91 M(-1.2%) |
| June 2010 | - | $176.11 M(-1.6%) |
| Mar 2010 | - | $178.91 M(-1.4%) |
| Dec 2009 | $181.42 M(+309.2%) | $181.42 M(+987.5%) |
| Sept 2009 | - | $16.68 M(-17.0%) |
| June 2009 | - | $20.09 M(-50.1%) |
| Mar 2009 | - | $40.28 M(-9.1%) |
| Dec 2008 | $44.33 M(-40.2%) | $44.33 M(-12.4%) |
| Sept 2008 | - | $50.62 M(-8.6%) |
| June 2008 | - | $55.42 M(-10.5%) |
| Mar 2008 | - | $61.90 M(-16.5%) |
| Dec 2007 | $74.18 M(+200.1%) | $74.18 M(-20.7%) |
| Sept 2007 | - | $93.55 M(-17.9%) |
| June 2007 | - | $113.94 M(-6.5%) |
| Mar 2007 | - | $121.84 M(+393.0%) |
| Dec 2006 | $24.71 M(-12.7%) | $24.71 M(-28.9%) |
| Sept 2006 | - | $34.74 M(-23.2%) |
| June 2006 | - | $45.23 M(+290.1%) |
| Mar 2006 | - | $11.59 M(-59.0%) |
| Dec 2005 | $28.31 M(+90.9%) | $28.31 M |
| Dec 2004 | $14.83 M(-98.3%) | - |
| Dec 2003 | $890.28 M(+33.9%) | - |
| Dec 2002 | $665.00 M(+27.1%) | - |
| Dec 2001 | $523.39 M(+65.5%) | - |
| Dec 2000 | $316.26 M(+208.6%) | - |
| Dec 1999 | $102.50 M(+42.6%) | - |
| Dec 1998 | $71.90 M(-77.4%) | - |
| Dec 1997 | $318.60 M(+343.1%) | - |
| Dec 1996 | $71.90 M(+166.3%) | - |
| Dec 1995 | $27.00 M(-13.2%) | - |
| Dec 1994 | $31.10 M | - |
FAQ
- What is Vanda Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual working capital year-on-year change?
- What is Vanda Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly working capital year-on-year change?
What is Vanda Pharmaceuticals annual working capital?
The current annual working capital of VNDA is $345.25 M
What is the all time high annual working capital for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual working capital is $890.28 M
What is Vanda Pharmaceuticals annual working capital year-on-year change?
Over the past year, VNDA annual working capital has changed by -$82.61 M (-19.31%)
What is Vanda Pharmaceuticals quarterly working capital?
The current quarterly working capital of VNDA is $343.30 M
What is the all time high quarterly working capital for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly working capital is $451.74 M
What is Vanda Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, VNDA quarterly working capital has changed by -$108.44 M (-24.00%)